Bayer | BAYN - Sales Revenues

Stock Price
40.48
Daily Change
1.21 3.08%
Monthly
7.69%
Yearly
107.93%
Q2 Forecast
38.53

Bayer reported EUR11.44B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Air Liquide EUR 13.22B 6.62B Dec/2025
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
Amarin USD 49.22M 451K Dec/2025
Arkema EUR 2.11B 80M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
BASF EUR 14.03B 300M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Beiersdorf EUR 2.31B 40M Dec/2025
Corteva USD 3.91B 1.29B Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Linde USD 8.76B 149M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Nutrien USD 7.03B 1.07B Dec/2025
Philips EUR 5.1B 797M Dec/2025
PPG Industries USD 3.91B 170M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
SAP EUR 9.68B 600M Dec/2025
Solvay EUR 995M 45M Dec/2025
UCB EUR 4.25B 764M Dec/2025
Umicore EUR 10.68B 8.89B Dec/2025
Vinci EUR 19.72B 320M Dec/2025